LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1298

Search options

  1. Article ; Online: Determinants of reinfection with SARS-CoV-2 Omicron variant.

    Bisharat, N / Campisi-Pinto, S

    The Journal of infection

    2023  Volume 87, Issue 2, Page(s) 163–165

    MeSH term(s) Humans ; SARS-CoV-2/genetics ; Reinfection ; COVID-19
    Language English
    Publishing date 2023-06-10
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2023.06.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-CoV-2 reinfection.

    Romera, I / Núñez, K / Calizaya, M / Baeza, I / Molina, R / Morillas, J

    Medicina intensiva

    2021  Volume 45, Issue 6, Page(s) 375–376

    MeSH term(s) Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Aged ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Viral/blood ; Antigens, Viral/blood ; Antiviral Agents/therapeutic use ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/drug therapy ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; COVID-19 Serological Testing ; Combined Modality Therapy ; DNA, Viral/analysis ; Diabetes Mellitus, Type 2/complications ; Drug Therapy, Combination ; Dyslipidemias/complications ; Enzyme-Linked Immunosorbent Assay ; Humans ; Hyperuricemia/complications ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Luminescent Measurements ; Male ; Methylprednisolone/therapeutic use ; Nasopharynx/virology ; Polymerase Chain Reaction ; Reinfection/blood ; Reinfection/diagnosis ; Reinfection/virology ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification ; SARS-CoV-2/pathogenicity
    Chemical Substances Antibodies, Monoclonal, Humanized ; Antibodies, Viral ; Antigens, Viral ; Antiviral Agents ; DNA, Viral ; Immunoglobulin G ; Immunoglobulin M ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; tocilizumab (I031V2H011) ; Alanine (OF5P57N2ZX) ; Methylprednisolone (X4W7ZR7023)
    Language English
    Publishing date 2021-05-02
    Publishing country Spain
    Document type Case Reports
    ISSN 2173-5727
    ISSN (online) 2173-5727
    DOI 10.1016/j.medine.2021.04.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A mini review of reinfection with the SARS-CoV-2 Omicron variant.

    Shen, Hongwei / Chen, Dingqiang / Li, Chenglin / Huang, Tingting / Ma, Wen

    Health science reports

    2024  Volume 7, Issue 4, Page(s) e2016

    Abstract: ... the probability, risk factors, and severity of severe acute respiratory syndrome coronavirus 2 Omicron variant ... of the dynamic zero-COVID policy in China in December, 2022, concerns regarding reinfection were raised ... reinfection, as well as the interval between infections, risk of onward transmission by reinfected cases, and ...

    Abstract Background: COVID-19 has caused severe morbidity and mortality worldwide. After the end of the dynamic zero-COVID policy in China in December, 2022, concerns regarding reinfection were raised while little was known due to the lack of surveillance data in this country.
    Aims: This study reviews the probability, risk factors, and severity of severe acute respiratory syndrome coronavirus 2 Omicron variant reinfection, as well as the interval between infections, risk of onward transmission by reinfected cases, and the role of booster vaccination against reinfection.
    Sources: References for this review were identified through searches of PubMed and Web of Science up to September 24, 2023.
    Results: The rate of reinfection ranges from 3.1% to 13.0%. Factors associated with a higher risk of reinfection include being female, having comorbidities, and being unvaccinated. Reinfection with the BA.4 or BA.5 variant occurs approximately 180 days after the initial infection. Reinfections are less clinically severe than primary infections, and there is evidence of lower transmissibility. The debate surrounding the effectiveness and feasibility of booster vaccinations in preventing reinfection continues.
    Conclusions: The reinfection rate during the Omicron epidemic is significantly higher than in previous epidemic periods. However, the symptoms and infectivity of reinfection were weaker than those of the prior infection. Medical staff and individuals at high risk of reinfection should be vigilant. The efficacy of booster vaccinations in reducing reinfection is currently under debate.
    Language English
    Publishing date 2024-04-10
    Publishing country United States
    Document type Journal Article
    ISSN 2398-8835
    ISSN (online) 2398-8835
    DOI 10.1002/hsr2.2016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.

    Chemaitelly, Hiam / Ayoub, Houssein H / Tang, Patrick / Yassine, Hadi M / Al Thani, Asmaa A / Hasan, Mohammad R / Coyle, Peter / Al-Kanaani, Zaina / Al-Kuwari, Einas / Jeremijenko, Andrew / Kaleeckal, Anvar Hassan / Latif, Ali Nizar / Shaik, Riyazuddin Mohammad / Abdul-Rahim, Hanan F / Nasrallah, Gheyath K / Al-Kuwari, Mohamed Ghaith / Butt, Adeel A / Al-Romaihi, Hamad Eid / Al-Thani, Mohamed H /
    Al-Khal, Abdullatif / Bertollini, Roberto / Abu-Raddad, Laith J

    Frontiers in medicine

    2024  Volume 11, Page(s) 1363045

    Abstract: ... of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, accurately defining reinfection poses ... for SARS-CoV-2 were attributed to the original infection. However, surpassing the 30-day post-infection ... methodological challenges. Conventionally, reinfection is defined as a positive test occurring at least 90 days ...

    Abstract Introduction: Reinfections are increasingly becoming a feature in the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, accurately defining reinfection poses methodological challenges. Conventionally, reinfection is defined as a positive test occurring at least 90 days after a previous infection diagnosis. Yet, this extended time window may lead to an underestimation of reinfection occurrences. This study investigated the prospect of adopting an alternative, shorter time window for defining reinfection.
    Methods: A longitudinal study was conducted to assess the incidence of reinfections in the total population of Qatar, from February 28, 2020 to November 20, 2023. The assessment considered a range of time windows for defining reinfection, spanning from 1 day to 180 days. Subgroup analyses comparing first versus repeat reinfections and a sensitivity analysis, focusing exclusively on individuals who underwent frequent testing, were performed.
    Results: The relationship between the number of reinfections in the population and the duration of the time window used to define reinfection revealed two distinct dynamical domains. Within the initial 15 days post-infection diagnosis, almost all positive tests for SARS-CoV-2 were attributed to the original infection. However, surpassing the 30-day post-infection threshold, nearly all positive tests were attributed to reinfections. A 40-day time window emerged as a sufficiently conservative definition for reinfection. By setting the time window at 40 days, the estimated number of reinfections in the population increased from 84,565 to 88,384, compared to the 90-day time window. The maximum observed reinfections were 6 and 4 for the 40-day and 90-day time windows, respectively. The 40-day time window was appropriate for defining reinfection, irrespective of whether it was the first, second, third, or fourth occurrence. The sensitivity analysis, confined to high testers exclusively, replicated similar patterns and results.
    Discussion: A 40-day time window is optimal for defining reinfection, providing an informed alternative to the conventional 90-day time window. Reinfections are prevalent, with some individuals experiencing multiple instances since the onset of the pandemic.
    Language English
    Publishing date 2024-03-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2024.1363045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Reinfection with SARS-CoV-2

    Pedro Sonie / Jorge Manuel-Silva / Alexandra Rafael / Luis Amorim-Alves

    Journal of Family Medicine and Primary Care, Vol 11, Iss 1, Pp 366-

    An inconvenient truth?

    2022  Volume 369

    Abstract: Data show that antibody-related immunity against SARS-CoV-2 may not be long-lasting. We report two ... cases regarded as cured from COVID-19, which presented again with symptoms and a positive SARS-CoV-2 RT ... associated with a positive RT-PCR test. All cases were immunocompetent. Anti-IgG-SARS-CoV-2 blood samples ...

    Abstract Data show that antibody-related immunity against SARS-CoV-2 may not be long-lasting. We report two cases regarded as cured from COVID-19, which presented again with symptoms and a positive SARS-CoV-2 RT-PCR test. Case one, a 60-year-old male, had a biphasic presentation of symptoms compatible with COVID-19 infection, associated with a positive RT-PCR test. Case two, a 25-year-old female, had a first positive RT-PCR test during hospital screening, and months later a symptomatic presentation of COVID-19, associated with a positive RT-PCR test. All cases were immunocompetent. Anti-IgG-SARS-CoV-2 blood samples were negative in both. Elevation of analytical inflammatory markers suggested new infection in both cases. COVID-19 reinfection may be a differential diagnosis and primary care physicians should acknowledge it. Previously cured patients should be encouraged to comply with health public preventive measures.
    Keywords family medicine ; infectious diseases ; public health ; Medicine ; R
    Language English
    Publishing date 2022-01-01T00:00:00Z
    Publisher Wolters Kluwer Medknow Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.

    Wang, Huanyu / Wright, Tori / Everhart, Kathy / Oyeniran, Sophonie J / Mejias, Asuncion / Leber, Amy L

    Journal of the Pediatric Infectious Diseases Society

    2023  Volume 12, Issue 4, Page(s) 198–204

    Abstract: ... reinfection, determine the number of SARS-CoV-2 reinfections, and characterize the intervals between two ... Background: Beginning in late 2021, we observed a significant increase in SARS-CoV-2 reinfections ... in pediatric patients evaluated at our institution. We aimed to characterize the children with SARS-CoV-2 ...

    Abstract Background: Beginning in late 2021, we observed a significant increase in SARS-CoV-2 reinfections in pediatric patients evaluated at our institution. We aimed to characterize the children with SARS-CoV-2 reinfection, determine the number of SARS-CoV-2 reinfections, and characterize the intervals between two infections in our patient population.
    Methods: From March 2020 to September 2022, we identified children ≤21 years old who had ≥2 SARS-CoV-2 infections using laboratory reports. We then defined the type of SARS-CoV-2 variant in the first and subsequent infections by mutation-specific typing or local epidemiology data. Clinical outcomes and the intervals between SARS-CoV-2 infections were assessed.
    Results: We identified 541 children with ≥2 SARS-CoV-2 infections. The median interval between two infections was 229 days. The hospitalization rate was lower in the second infection. Reinfection counts were higher during the periods that Omicron variants predominated. Reinfection occurred more rapidly when Omicron variants were circulating with some occurring in less than 90 days.
    Conclusions: As SARS-CoV-2 continues to evolve, there is a need for ongoing surveillance to identify the frequency and time interval between reinfections and to re-evaluate the definition of SARS-CoV-2 reinfections.
    MeSH term(s) Humans ; Child ; Young Adult ; Adult ; Ohio/epidemiology ; SARS-CoV-2/genetics ; Reinfection/epidemiology ; COVID-19/epidemiology
    Language English
    Publishing date 2023-02-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piad017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Epidemiological assessment of SARS-CoV-2 reinfection.

    Almadhi, Marwa / Alsayyad, Adel Salman / Conroy, Ronan / Atkin, Stephen / Awadhi, Abdulla Al / Al-Tawfiq, Jaffar A / AlQahtani, Manaf

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

    2022  Volume 123, Page(s) 9–16

    Abstract: Objectives: SARS-CoV-2 vaccination has been shown to reduce infection severity ... however, the reinfection frequency among unvaccinated, partially vaccinated, and fully vaccinated individuals remains ... Methods: This retrospective epidemiological report included 1362 COVID-19 reinfection cases in Bahrain ...

    Abstract Objectives: SARS-CoV-2 vaccination has been shown to reduce infection severity; however, the reinfection frequency among unvaccinated, partially vaccinated, and fully vaccinated individuals remains unclear. This study aims to elucidate the rates of and factors associated with such occurrences.
    Methods: This retrospective epidemiological report included 1362 COVID-19 reinfection cases in Bahrain between April 2020 and July 2021. We analyzed differences in disease severity and reinfection characteristics among various vaccination statuses: fully vaccinated, interrupted vaccination, one-dose vaccination, postreinfection vaccination, and unvaccinated.
    Results: Reinfection cases increased from zero per month in April-June 2020 to a sharp peak of 579 in May 2021. A significantly larger proportion of reinfected individuals were male (60.3%, P <0.0001). Reinfection episodes were highest among those 30-39 years of age (29.7%). The fewest reinfection episodes occurred at 3-6 months after the first infection (20.6%) and most occurred ≥9 months after the initial infection (46.4%). Most individuals were asymptomatic during both episodes (35.7%). Reinfection disease severity was mild, with vaccinated patients less likely to have symptomatic reinfection (odds ratio 0.71, P = 0.004). Only 6.6% of reinfected patients required hospitalization. One death was recorded; the patient belonged to the unvaccinated group.
    Conclusion: Vaccine-induced immunity and previous infection with or without vaccination were effective in reducing reinfection disease severity.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines ; Female ; Humans ; Male ; Reinfection/epidemiology ; Retrospective Studies ; SARS-CoV-2
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2022-08-02
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 1331197-9
    ISSN 1878-3511 ; 1201-9712
    ISSN (online) 1878-3511
    ISSN 1201-9712
    DOI 10.1016/j.ijid.2022.07.075
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Reinfection and reactivation of SARS-CoV-2.

    Dowran, Razieh / Damavandi, Amirmasoud Rayati / Azad, Talat Mokhtari

    Future virology

    2022  

    Abstract: As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge ... around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon ... reinfection occurs as the result of diminishing protection conferred by antibodies, especially IgG ...

    Abstract As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon, reinfection occurs as the result of diminishing protection conferred by antibodies, especially IgG. Reactivation is more concerned with the role of various elements including shedding lingering viral RNA for a prolonged time and incomplete resolution of infection along with the insight of dormant viral exosomes' role. The concept of testing positive after two consecutive negative results requires proper discrimination of reinfection from reactivation. In this review, we summarized the current evidence for possible mechanisms leading to viral reactivation or test re-positivity. We also pointed out risk factors associated with both reinfection and reactivation.
    Language English
    Publishing date 2022-09-26
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2254606-6
    ISSN 1746-0808 ; 1746-0794
    ISSN (online) 1746-0808
    ISSN 1746-0794
    DOI 10.2217/fvl-2021-0212
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Serological Markers of SARS-CoV-2 Reinfection.

    Siddiqui, Sameed M / Bowman, Kathryn A / Zhu, Alex L / Fischinger, Stephanie / Beger, Samuel / Maron, Jenny S / Bartsch, Yannic C / Atyeo, Caroline / Gorman, Matthew J / Yanis, Ahmad / Hultquist, Judd F / Lorenzo-Redondo, Ramon / Ozer, Egon A / Simons, Lacy M / Talj, Rana / Rankin, Danielle A / Chapman, Lindsay / Meade, Kyle / Steinhart, Jordan /
    Mullane, Sean / Siebert, Suzanne / Streeck, Hendrik / Sabeti, Pardis / Halasa, Natasha / Musk, Elon R / Barouch, Dan H / Menon, Anil S / Nilles, Eric J / Lauffenburger, Douglas A / Alter, Galit

    mBio

    2022  Volume 13, Issue 1, Page(s) e0214121

    Abstract: ... As such, the ability to detect reexposure to and reinfection by SARS-CoV-2 is a key component for global protection ... against SARS-CoV-2, it is likely that SARS-CoV-2 will remain endemic, fueled by the rise of more ... infectious SARS-CoV-2 variants. Moreover, in the setting of waning natural and vaccine immunity, reinfections ...

    Abstract As public health guidelines throughout the world have relaxed in response to vaccination campaigns against SARS-CoV-2, it is likely that SARS-CoV-2 will remain endemic, fueled by the rise of more infectious SARS-CoV-2 variants. Moreover, in the setting of waning natural and vaccine immunity, reinfections have emerged across the globe, even among previously infected and vaccinated individuals. As such, the ability to detect reexposure to and reinfection by SARS-CoV-2 is a key component for global protection against this virus and, more importantly, against the potential emergence of vaccine escape mutations. Accordingly, there is a strong and continued need for the development and deployment of simple methods to detect emerging hot spots of reinfection to inform targeted pandemic response and containment, including targeted and specific deployment of vaccine booster campaigns. In this study, we identify simple, rapid immune biomarkers of reinfection in rhesus macaques, including IgG3 antibody levels against nucleocapsid and FcγR2A receptor binding activity of anti-RBD antibodies, that are recapitulated in human reinfection cases. As such, this cross-species analysis underscores the potential utility of simple antibody titers and function as price-effective and scalable markers of reinfection to provide increased resolution and resilience against new outbreaks.
    MeSH term(s) Animals ; Humans ; Reinfection ; Macaca mulatta ; SARS-CoV-2 ; COVID-19 ; Immunoglobulin G ; Antibodies, Viral ; Antibodies, Neutralizing
    Chemical Substances Immunoglobulin G ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2022-01-25
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mbio.02141-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Reinfection with SARS-CoV-2: An inconvenient truth?

    Sonié, Pedro / Manuel-Silva, Jorge / Rafael, Alexandra / Amorim-Alves, Luís

    Journal of family medicine and primary care

    2022  Volume 11, Issue 1, Page(s) 366–369

    Abstract: Data show that antibody-related immunity against SARS-CoV-2 may not be long-lasting. We report two ... cases regarded as cured from COVID-19, which presented again with symptoms and a positive SARS-CoV-2 RT ... associated with a positive RT-PCR test. All cases were immunocompetent. Anti-IgG-SARS-CoV-2 blood samples ...

    Abstract Data show that antibody-related immunity against SARS-CoV-2 may not be long-lasting. We report two cases regarded as cured from COVID-19, which presented again with symptoms and a positive SARS-CoV-2 RT-PCR test. Case one, a 60-year-old male, had a biphasic presentation of symptoms compatible with COVID-19 infection, associated with a positive RT-PCR test. Case two, a 25-year-old female, had a first positive RT-PCR test during hospital screening, and months later a symptomatic presentation of COVID-19, associated with a positive RT-PCR test. All cases were immunocompetent. Anti-IgG-SARS-CoV-2 blood samples were negative in both. Elevation of analytical inflammatory markers suggested new infection in both cases. COVID-19 reinfection may be a differential diagnosis and primary care physicians should acknowledge it. Previously cured patients should be encouraged to comply with health public preventive measures.
    Language English
    Publishing date 2022-01-31
    Publishing country India
    Document type Case Reports
    ZDB-ID 2735275-4
    ISSN 2278-7135 ; 2249-4863
    ISSN (online) 2278-7135
    ISSN 2249-4863
    DOI 10.4103/jfmpc.jfmpc_1490_21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top